Clinical Profile and Treatment Outcomes of Herpes Simplex Virus Keratitis at the Philippine General Hospital.
- 1Department of Ophthalmology and Visual Sciences, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines.
- 2Eye Institute, St. Luke's Medical Center, Quezon City, Philippines.
Abstract
Herpes simplex virus (HSV) keratitis is a significant cause of infectious corneal disease and visual impairment, with clinical manifestations ranging from epithelial to stromal and endothelial involvement. Despite its reported burden in the Philippines, updated local data on its clinical presentation, treatment outcomes, recurrence, and visual outcomes are limited. The study aimed to describe the demographic profile, clinical manifestations, treatment outcomes, visual outcomes, and recurrence rates of locally diagnosed Herpes simplex virus (HSV) keratitis cases. This cross-sectional, retrospective review examined medical records of clinically diagnosed HSV keratitis patients at the Philippine General Hospital from 2013 to 2023. Data on demographics, clinical presentation, initial and latest uncorrected distance visual acuity (UDVA), treatment outcomes, recurrence rates, and follow-up duration were collected. Ninety-eight (98) eyes of 97 patients were included in the study. The average patient age was 47 years, with 37% in the 41 to 60-year age group. A higher predilection for males (63%) was observed. The most common clinical presentation was epithelial keratitis (26%), followed by stromal keratitis (24%), keratouveitis (22%), stromal scarring (14%), and endothelial keratitis (13%). Ninety-nine percent of cases were unilateral, and 87% presented with decreased corneal sensation. The mean time from symptom onset to consultation was 6 weeks, with an average follow-up duration of 27 months. Epithelial keratitis responded well to topical antiviral in 92% of cases. Topical steroids combined with antiviral therapy showed good responses in stromal keratitis (41%), endothelial keratitis (92%), and keratouveitis (60%). Four eyes needed tectonic penetrating keratoplasty (PKP) for corneal perforation, while 5 eyes underwent optical PKP. The overall recurrence rate was 35%, with no recurrences in patients on prophylactic oral acyclovir (ACV), compared to 33% in those without (p = 0.001). The mean uncorrected distance visual acuity (UDVA) was 1.55 ± 1.07, which significantly improved to 1.20 ± 1.14 at the latest visit (p = 0.001). HSV keratitis was more common in the middle-aged group, with epithelial keratitis being the leading presentation. Early diagnosis and appropriate treatment significantly improved visual outcomes and reduced corneal complications. One-third of cases recurred, highlighting the need for long-term monitoring. Prophylactic oral ACV may reduce recurrence rates, but further research is warranted to assess its cost-effectiveness.
Related
- Clinicopathological Profile, Treatment Patterns and Documented Clinical Outcomes of Women with Breast Cancer at Shendi Hospital, Sudan: A Retrospective, Single-Center, Hospital-Based Cross-Sectional Study.
- Disciform Keratitis That Improves With Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitor Treatment for Ovarian Cancer but Recurs Upon Discontinuation of Treatment
- Prehospital predictors of clinical outcomes in out-of-hospital cardiac arrest with pulseless electrical activity: a JCS-ReSS report
- Clinical profile, risk factors and in-hospital outcomes of ST-segment elevation myocardial infarction in young versus older adults: a 5-year retrospective cohort study at a tertiary care centre in Riyadh, Saudi Arabia.
- The impact of hospital waiting lists on labour market outcomes: quasi-experimental evidence from musculoskeletal treatment in England
BibTeX
@article{rivera2026clinical,
title = {{Clinical Profile and Treatment Outcomes of Herpes Simplex Virus Keratitis at the Philippine General Hospital.}},
author = {Jayvee S Rivera and Ruben Lim Bon Siong and Reginald Robert G Tan},
journal = {Acta medica Philippina},
year = {2026},
month = sep,
doi = {10.47895/amp.v60i17.13484},
url = {https://europepmc.org/article/MED/42952921},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Clinical Profile and Treatment Outcomes of Herpes Simplex Virus Keratitis at the Philippine General Hospital.
AU - Jayvee S Rivera
AU - Ruben Lim Bon Siong
AU - Reginald Robert G Tan
PY - 2026
DA - 2026/09/15
JO - Acta medica Philippina
DO - 10.47895/amp.v60i17.13484
UR - https://europepmc.org/article/MED/42952921
AB - Herpes simplex virus (HSV) keratitis is a significant cause of infectious corneal disease and visual impairment, with clinical manifestations ranging from epithelial to stromal and endothelial involvement. Despite its reported burden in the Philippines, updated local data on its clinical presentation, treatment outcomes, recurrence, and visual outcomes are limited. The study aimed to describe the demographic profile, clinical manifestations, treatment outcomes, visual outcomes, and recurrence rates of locally diagnosed Herpes simplex virus (HSV) keratitis cases. This cross-sectional, retrospective review examined medical records of clinically diagnosed HSV keratitis patients at the Philippine General Hospital from 2013 to 2023. Data on demographics, clinical presentation, initial and latest uncorrected distance visual acuity (UDVA), treatment outcomes, recurrence rates, and follow-up duration were collected. Ninety-eight (98) eyes of 97 patients were included in the study. The average patient age was 47 years, with 37% in the 41 to 60-year age group. A higher predilection for males (63%) was observed. The most common clinical presentation was epithelial keratitis (26%), followed by stromal keratitis (24%), keratouveitis (22%), stromal scarring (14%), and endothelial keratitis (13%). Ninety-nine percent of cases were unilateral, and 87% presented with decreased corneal sensation. The mean time from symptom onset to consultation was 6 weeks, with an average follow-up duration of 27 months. Epithelial keratitis responded well to topical antiviral in 92% of cases. Topical steroids combined with antiviral therapy showed good responses in stromal keratitis (41%), endothelial keratitis (92%), and keratouveitis (60%). Four eyes needed tectonic penetrating keratoplasty (PKP) for corneal perforation, while 5 eyes underwent optical PKP. The overall recurrence rate was 35%, with no recurrences in patients on prophylactic oral acyclovir (ACV), compared to 33% in those without (p = 0.001). The mean uncorrected distance visual acuity (UDVA) was 1.55 ± 1.07, which significantly improved to 1.20 ± 1.14 at the latest visit (p = 0.001). HSV keratitis was more common in the middle-aged group, with epithelial keratitis being the leading presentation. Early diagnosis and appropriate treatment significantly improved visual outcomes and reduced corneal complications. One-third of cases recurred, highlighting the need for long-term monitoring. Prophylactic oral ACV may reduce recurrence rates, but further research is warranted to assess its cost-effectiveness.
SN - 0001-6071
SN - 2094-9278
ER -